NewslettersMesenchymal Cell NewsInhibition of TGF-β Signaling Enhances Osteogenic Potential of iPSC-Derived MSCsBy Emily Salmini - March 10, 2025025Researchers examined the impact of the selective TGF-β inhibitor SB431542 on iPSC-derived MSC differentiation, demonstrating that TGF-β inhibition enhanced osteogenic potential and reduced premature senescence.[Scientific Reports]Full Article